Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_assertion type Assertion NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_head.
- NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_provenance.
- NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_assertion evidence source_evidence_literature NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_provenance.
- NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_assertion SIO_000772 23861247 NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_provenance.
- NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_assertion wasDerivedFrom befree-20150227 NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_provenance.
- NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_assertion wasGeneratedBy ECO_0000203 NP986585.RAU-hRQ0GcbjFrlunzFzzhWw8rMuDfvJYESgk7P3lqaxA130_provenance.